The Biogen Foundation's STAR Initiative--for Science, Teacher support, Access and Resources--is intended to strengthen and support educational offerings in these cities by helping increase access to STEM resources and opportunities for students currently underrepresented in STEM college or career pathways.
Through a coordinated network of grantees, STAR endeavors to help low-income students develop and sustain their interest in STEM, gain necessary STEM exposure and enrichment opportunities, and successfully transition into post-secondary education in pursuit of STEM careers.
The Biogen Foundation will soon be soliciting proposals from nonprofits providing services in the areas of STEM access, exploration, and preparedness for students in grades 6-12.
Successful applicants will partner with Cambridge and/or Somerville public schools by providing in- or out-of-school STEM awareness, exploration, and skill-building support and activities.
Organizations selected to receive grants will become part of a coordinated provider network managed by the Biogen Foundation. The STAR initiative is intended to complement, supplement, and strengthen the existing STEM education landscapes in Cambridge and Somerville.
The Biogen Foundation supports access to science education and to essential human services for children and their families in the communities in which Biogen facilities are located.
The foundation is committed to sparking a passion for science and discovery, supporting effective science education initiatives, and strengthening efforts to make science education and science careers accessible to diverse populations.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development